Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Constitutive deficiency in DNA mismatch repair: is it time for Lynch III?

Felton KE, Gilchrist DM, Andrew SE.

Clin Genet. 2007 Jun;71(6):499-500.

PMID:
17539898
2.

Constitutive deficiency in DNA mismatch repair.

Felton KE, Gilchrist DM, Andrew SE.

Clin Genet. 2007 Jun;71(6):483-98. Review.

PMID:
17539897
3.

Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.

Baris HN, Barnes-Kedar I, Toledano H, Halpern M, Hershkovitz D, Lossos A, Lerer I, Peretz T, Kariv R, Cohen S, Half EE, Magal N, Drasinover V, Wimmer K, Goldberg Y, Bercovich D, Levi Z.

Pediatr Blood Cancer. 2016 Mar;63(3):418-27. doi: 10.1002/pbc.25818.

PMID:
26544533
4.

Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.

Steinke V, Holzapfel S, Loeffler M, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Pox C, Royer-Pokora B, von Knebel-Doeberitz M, Büttner R, Propping P, Engel C; German HNPCC Consortium..

Int J Cancer. 2014 Jul 1;135(1):69-77. doi: 10.1002/ijc.28650.

5.

Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan.

Chen JR, Chiang JM, Changchien CR, Chen JS, Tang RP, Wang JY.

Br J Surg. 2008 Jan;95(1):102-10.

PMID:
18064717
6.

Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.

Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, Papadopoulos N, Kinzler KW, Vogelstein B, Peltomäki P, Kolodner RD, Nilbert M, Lindblom A.

J Natl Cancer Inst. 2007 Feb 21;99(4):291-9.

7.

Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.

Clay MR, Allison KH, Folkins AK, Longacre TA.

Am J Surg Pathol. 2014 Nov;38(11):1494-500. doi: 10.1097/PAS.0000000000000259.

PMID:
24921635
8.

Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.

Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA.

Am J Surg Pathol. 2014 Nov;38(11):1501-9. doi: 10.1097/PAS.0000000000000321.

9.

Mismatch repair gene deficiency and genetic anticipation in Lynch syndrome: myth or reality?

Ponti G, Ruini C, Tomasi A.

Dis Colon Rectum. 2015 Jan;58(1):141-2. doi: 10.1097/DCR.0000000000000275. Review. No abstract available.

PMID:
25489705
10.

Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study.

Park JG, Kim DW, Hong CW, Nam BH, Shin YK, Hong SH, Kim IJ, Lim SB, Aronson M, Bisgaard ML, Brown GJ, Burn J, Chow E, Conrad P, Douglas F, Dunlop M, Ford J, Greenblatt MS, Heikki J, Heinimann K, Lynch EL, Macrae F, McKinnon WC, Möeslein G, Rossi BM, Rozen P, Schofield L, Vaccaro C, Vasen H, Velthuizen M, Viel A, Wijnen J; International Society for Gastrointestinal Hereditary Tumours..

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3389-93.

11.

Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm.

Everett JN, Raymond VM, Dandapani M, Marvin M, Kohlmann W, Chittenden A, Koeppe E, Gustafson SL, Else T, Fullen DR, Johnson TM, Syngal S, Gruber SB, Stoffel EM.

JAMA Dermatol. 2014 Dec;150(12):1315-21.

12.

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.

Kloor M, Huth C, Voigt AY, Benner A, Schirmacher P, von Knebel Doeberitz M, Bläker H.

Lancet Oncol. 2012 Jun;13(6):598-606. doi: 10.1016/S1470-2045(12)70109-2.

PMID:
22552011
14.

A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.

Thompson BA, Martins A, Spurdle AB.

Clin Genet. 2015 Feb;87(2):100-8. doi: 10.1111/cge.12450. Review.

PMID:
24989436
15.

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.

Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA.

J Natl Cancer Inst. 2012 Sep 19;104(18):1363-72.

16.

Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases.

Lotsari JE, Gylling A, Abdel-Rahman WM, Nieminen TT, Aittomäki K, Friman M, Pitkänen R, Aarnio M, Järvinen HJ, Mecklin JP, Kuopio T, Peltomäki P.

Breast Cancer Res. 2012 Jun 12;14(3):R90.

17.

Epigenetic mechanisms in the pathogenesis of Lynch syndrome.

Peltomäki P.

Clin Genet. 2014 May;85(5):403-12. doi: 10.1111/cge.12349. Review.

PMID:
24443998
18.

Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.

Hegan DC, Narayanan L, Jirik FR, Edelmann W, Liskay RM, Glazer PM.

Carcinogenesis. 2006 Dec;27(12):2402-8.

19.

In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response.

Meijer TW, Hoogerbrugge N, Nagengast FM, Ligtenberg MJ, van Krieken JH.

Histopathology. 2009 Oct;55(4):414-22. doi: 10.1111/j.1365-2559.2009.03403.x.

PMID:
19817892
20.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B, Macrae FA, Ahnen DJ, Casey G, Gallinger S, Haile RW, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

J Natl Cancer Inst. 2015 Jun 24;107(9). pii: djv170. doi: 10.1093/jnci/djv170.

Items per page

Supplemental Content

Support Center